Your browser doesn't support javascript.
loading
Serum miRNA profiles are altered in patients with primary sclerosing cholangitis receiving high-dose ursodeoxycholic acid.
Hochberg, Jessica T; Sohal, Aalam; Handa, Priya; Maliken, Bryan D; Kim, Take-Kyun; Wang, Kai; Gochanour, Eric; Li, Yu; Rose, J Bart; Nelson, James E; Lindor, Keith D; LaRusso, Nicholas F; Kowdley, Kris V.
Affiliation
  • Hochberg JT; Liver Institute Northwest, Seattle, WA, USA.
  • Sohal A; Seattle Children's Hospital/University of Washington, Seattle, WA, USA.
  • Handa P; Miami Transplant Institute at University of Miami, Miami, FL, USA.
  • Maliken BD; Liver Institute Northwest, Seattle, WA, USA.
  • Kim TK; Benaroya Research Institute, Seattle, WA, USA.
  • Wang K; Benaroya Research Institute, Seattle, WA, USA.
  • Gochanour E; Institute for Systems Biology, Seattle, WA, USA.
  • Li Y; Institute for Systems Biology, Seattle, WA, USA.
  • Rose JB; Liver Institute Northwest, Seattle, WA, USA.
  • Nelson JE; Benaroya Research Institute, Seattle, WA, USA.
  • Lindor KD; Benaroya Research Institute, Seattle, WA, USA.
  • LaRusso NF; Benaroya Research Institute, Seattle, WA, USA.
  • Kowdley KV; Division of Gastroenterology and Hepatology, Mayo Clinic Rochester, MN, USA.
JHEP Rep ; 5(6): 100729, 2023 Jun.
Article in En | MEDLINE | ID: mdl-37179785
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials Language: En Journal: JHEP Rep Year: 2023 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials Language: En Journal: JHEP Rep Year: 2023 Type: Article Affiliation country: United States